Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirbanibulin 1% Ointment for Pediatric Hand Warts
NCT06791525Phase 4Recruiting
- Sponsor
- The Skin Center Dermatology Group
- Start
- May 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tirbanibulin in warts, sponsored by The Skin Center Dermatology Group. Primary endpoint: Wart Resolution. Started May 2025; status: recruiting.
02
Drugs
tirbanibulin
03
Conditions
warts
Beyond the preview
Go deeper on NCT06791525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06791525.